Company performance
Add to research
Current Price
as of Jun 20, 2025$0.14
P/E Ratio
N/A
Market Cap
$614.18K
Description
Add to research
Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Services
- IndustryMedical/Nursing Services
- TickerPROG
- Price$0.1358-16.17%
Trading Information
- Market cap$0.61M
- Float96.63%
- Average Daily Volume (1m)9,838
- Average Daily Volume (3m)13,430
- EPS-$10.87
Company
- Revenue$0.89M
- Rev growth (1yr)N/A
- Net income-$22.22M
- Gross margin-246.88%
- EBITDA margin-50,362.50%
- EBITDA-$16.12M
- EV$54.77M
- EV/Revenue61.40
- P/EN/A
- P/S0.56
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
Factset Street Account
Biora Therapeutics to submit updated IND application for BT-600 ($2.44, 0.00) (2023-10-23T21:32:54Z)
Earnings Calls
Factset